Fig. 4

Effects of DOS and OH-SeMet supplementation on the protein metabolism and lipid metabolism in LD. A Relative mRNA expression of UBA1, UBA2, UBE2B, UBE2K, ACACA and FASN; B Activity of UBE3; C Protein expression of AKT-mTOR and AMPK-SREBP-1 signalling pathway; D Activity of ATGL; E Relative protein abundance of p-AKT; F Relative protein abundance of p-mTOR; G Relative protein abundance of p-4E-BP1; H Relative protein abundance of p-S6K1; I Relative protein abundance of p-AMPKα; J Relative protein abundance of SREBP-1. Results were expressed as mean ± SD (n = 6 or 4), different letters indicate significant differences (P < 0.05)